全球基因毒性测试市场-行业规模、份额、趋势、机会和预测，2018-2028F 按成分、类型、应用和地区分析

全球基因毒性检测市场预计在预测期内将出现令人瞩目的增长。

这是由于人们对药物发现以及针对各种疾病的新疗法和疗法的开发越来越感兴趣。 此外，各种体外个性化药物的使用率提高也有望在未来几年推动市场增长。 此外，对用于进行各种调查的人性化动物模型的需求不断增长，预计将为未来几年的市场增长创造有利可图的机会。 此外，许多活跃于基因毒性测试行业的公司在市场上的存在预计将在预测期内推动市场增长。 此外，全球越来越多的老年人易患各种类型的慢性病，□□这将进一步增加对遗传毒性测试的需求，预计这将推动市场增长到 2028 年。 此外，预计在预测期内，遗传毒性测试在食品、化妆品和药品等各种最终用户行业的应用越来越多，将支持遗传毒性测试市场。 药物开发和发现活动的增加进一步推动了市场的增长。 此外，药物基因组学的日益普及有望在未来几年为市场增长创造有利可图的机会。 此外，新兴国家越来越多地采用先进技术，预计将进一步增加对遗传毒性测试的需求并支持市场的增长。 2015 年，42% 的在研药物有可能成为个性化药物，美国 73% 的抗癌药物有可能成为个性化药物。

对个性化医疗的需求不断增长

在预测期内，对治疗各种疾病的个性化医疗需求不断增长，预计将推动市场增长。 分子医学的进步催生了药物基因组学的新概念，使个性化医疗能够提供更好的药物选择和靶向治疗。 此外，它有助于减少副作用并改善患者体验。 在药物开发的早期阶段增加研发投入，有望在药物达到高成本临床阶段之前增加体内毒理学方法的使用。 这将增加对基因毒理学服务的需求。 对于许多转基因食品、药品、化学品、杀虫剂和疫苗，一些国家的政府要求将毒性测试作为进出口的先决条件。 2006 年至 2010 年间，美国报告称对个性化医疗的投资增加了 73%。

启动研发活动

随着各种候选药物获得批准以及临床前化合物的接受度不断提高，预计基因毒性测试市场将在未来几年不断增长。 在药物开发的早期阶段进行密集的研究和开发活动，以实现药物发现的主要目标。 因此，预计在预测期内对遗传毒性测试服务的需求将会增加。 活跃于食品、化妆品和医疗保健领域的各种公司都在采用基因毒理学，导致对基因毒理学服务的需求增加，并推动了市场的增长。 2020 年联邦政府医疗保健支出增长 36.0%，远高于 2019 年 5.9% 的增幅。

市场细分

营销人员

Thermo Fisher Scientific, Inc.、Eurofins Scientific SE、Jubilant Life Sciences Limited、Syngene International Limited、Gentronix Ltd.、Inotiv Inc.、Charles River Laboratories International, Inc.、Merck KGaA、Toxikon Corporation、Gentronix Limited 的示例基因毒性测试市场的主要参与者。

近期发展

• Innotive Inc. 于 2022 年 7 月宣布，它将继续扩大其执行体外细胞遗传学和细菌检测的遗传毒性测试的能力。 这将有助于支持新治疗药物的开发。
• 2021 年 11 月，总部位于英国的合同研究组织 Gentronix 宣布筹集了约 743,000 美元（700 欧元），以加强其眼睛、遗传和皮肤毒性测试能力并扩建其实验室设施。

研究范围：

本报告将全球基因毒性检测市场分为以下几类，并详细介绍了行业趋势：

基因毒性测试市场，按成分分类：

• 试剂和耗材
• 化验
• 服务详情

基因毒性测试市场，按类型：

• 体外
• 体内

基因毒性测试市场，按应用分类：

• 製药/生物技术
• 化妆品
• 食物
• 其他

按地区划分的遗传毒性检测市场：

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚
• 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
• 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 埃及
  • 土耳其人

竞争格局

公司概况：对全球遗传毒性测试市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

• 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析

内容

第 1 章概述

• 市场定义
• 市场范围
  • 目标市场
  • 调查年份
  • 主要市场细分

第二章研究方法论

• 调查目的
• 基线调查方法
• 主要行业合作伙伴
• 主要协会和次要信息
• 调查方法
• 数据三角测量和验证
• 假设和限制

第 3 章执行摘要

• 市场概览
• 主要市场细分概述
• 主要市场参与者概览
• 主要地区/国家概览
• 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第 5 章基因毒性测试的全球市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按组成部分（试剂/耗材、化验、服务）
  • 按类型（体外与体内）
  • 按应用（製药/生物技术、化妆品、食品、其他）
  • 按地区
  • 按公司分类（2022 年）
• 市场地图
  • 按组件
  • 按类型
  • 通过申请
  • 按地区

第6章北美基因毒性检测市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按组件
  • 按类型
  • 通过申请
  • 按国家
• 北美：国家/地区分析
  • 美国
  • 加拿大
  • 墨西哥

第7章欧洲遗传毒性检测市场前景

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按组件
  • 按类型
  • 通过申请
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第八章亚太地区基因毒性检测市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按组件
  • 按类型
  • 通过申请
  • 按国家
• 亚太地区：国家/地区分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第9章南美基因毒性检测市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按组件
  • 按类型
  • 通过申请
  • 按国家
• 南美洲：：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第10章中东和非洲基因毒性检测市场前景

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按组件
  • 按类型
  • 通过申请
  • 按国家
• MEA：国家分析
  • 南非遗传毒性试验
  • 沙特阿拉伯遗传毒性试验
  • 阿联酋遗传毒性试验
  • 埃及遗传毒性试验
  • Turkiye 遗传毒性试验

第 11 章市场动态

• 司机
• 任务

第12章市场趋势与发展

• 近期趋势
• 併购
• 产品发布

第13章竞争格局

• Business Overview
• Product Offerings
• Recent Developments
• Financials（As Reported）
• Key Personnel
• SWOT Analysis
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Jubilant Life Sciences Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Charles River Laboratories International, Inc.
  • Merck KGaA
  • Toxikon Corporation
  • Gentronix Limited

第14章 战略建议

Global genetic toxicology testing market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing focus on drug discovery, and the development of new treatments or therapies for various diseases. Additionally, the growing use of personalized medicine in various in vitro procedures is expected to drive market growth in the coming years. Besides, the increasing demand for humanized animal models for conducting different research is expected to create lucrative opportunities for market growth in the coming years. Additionally, the presence of numerous players operating in the market working in the genetic toxicology testing industry is expected to drive market growth in the forecast period. Additionally, the growing geriatric population across the globe which is susceptible to different kinds of chronic diseases is further expected to increase the demand for genetic toxicology testing, thereby fuelling the market growth through 2028. Besides, the growing application of genetic toxicology testing across various end-user industries including food, cosmetics, and pharmaceutical, among others is expected to support the genetic toxicology testing market during the forecast period. The increasing drug development and discovery activities are further supporting the market growth. Also, the rising popularity of pharmacogenomics is expected to create lucrative opportunities for market growth in the coming years. Furthermore, the increasing adoption of advanced technology in emerging countries is further expected to increase the demand for genetic toxicology testing, thereby supporting market growth. In 2015, 42 percent of all drugs, in development, had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines in the United States.

Growing Demand for Personalized Medicine

Increasing demand for personalized medicine for the treatment of different diseases is expected to propel market growth in the forecast period. The advancement of molecular medicine has resulted in the novel concept of pharmacogenomics where personalized medicine can provide better medication selection and targeted therapy. Additionally, it helps to reduce the side effects along with improving patient experience. Increasing research and development investments in the early stages of drug development are also expected to increase the utilization of in-vivo toxicology techniques before the drug reaches the high-cost clinical stages. This increases the demand for genetic toxicology services. For many genetically modified food, drugs, chemicals, pesticides, and vaccines, several countries' government requires toxicology testing as a pre-requisite for imports and exports. Between 2006 and 2010, investment in personalized medicine in the United States grew by 73 percent, as per reports.

Increasing R&D activities

Increasing the approval of various drug candidates and increasing acceptance of compounds in the preclinical stages is expected to grow the genetic toxicology testing market over the years. To achieve the main goal of drug discovery, intensive research, and development activities are conducted in the early stages of drug development. This, in turn, enhances the demand for genetic toxicology services in the forecast period. Different companies operating in the food, cosmetic, and healthcare sector are adopting genetic toxicology leading to a rise in demand for genetic toxicology services, thereby fuelling the growth of the market. Federal government spending for health care grew 36.0% in 2020, significantly faster than the 5.9% growth in 2019.

Market Segmentation

Global genetic toxicology testing market can be segmented by component, type, application, and by region. Based on components, the market can be segmented into Reagents & Consumables, Assays, and Services. Based on type, the market can be divided into In Vitro and In Vivo. Based on application, the market can be grouped into Pharmaceutical & Biotechnology, Cosmetics, Food, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among the different countries, the United States dominated the global genetic toxicology testing market, on account of the growing demand for personalized medicine and increasing investment in the healthcare industry in the country.

Market Players

Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited are some of the leading players operating in the Global Genetic Toxicology Testing Market.

Recent Developments

• Inotiv, Inc. in July 2022 announced that it would be continuing to expand its capacity to conduct genetic toxicology studies for in vitro cytogenetics and bacterial assays. This will help in supporting the development of novel therapeutics.
• In November 2021, United Kingdom based contract research organization, Gentronix announced that they have raised around USD 743,000(Euro 700) for the expansion of its lab facilities by enhancing its capacity for ocular, genetic, and skin toxicology testing.

Report Scope:

In this report, global genetic toxicology testing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genetic Toxicology Testing Market, By Component:

• Reagents & Consumables
• Assays
• Services

Genetic Toxicology Testing Market, By Type:

• In Vitro
• In Vivo

Genetic Toxicology Testing Market, By Application:

• Pharmaceutical & Biotechnology
• Cosmetics
• Food
• Others

Genetic Toxicology Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Genetic Toxicology Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genetic Toxicology Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Reagents & Consumables, Assays, Services)
  • 5.2.2. By Type (In Vitro v/s In Vivo)
  • 5.2.3. By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1. By Component
  • 5.3.2. By Type
  • 5.3.3. By Application
  • 5.3.4. By Region

6. North America Genetic Toxicology Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Genetic Toxicology Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Genetic Toxicology Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Genetic Toxicology Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application

7. Europe Genetic Toxicology Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Genetic Toxicology Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Genetic Toxicology Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Genetic Toxicology Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Genetic Toxicology Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Genetic Toxicology Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application

8. Asia-Pacific Genetic Toxicology Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Genetic Toxicology Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
  • 8.3.2. India Genetic Toxicology Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Genetic Toxicology Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Genetic Toxicology Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Genetic Toxicology Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application

9. South America Genetic Toxicology Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Genetic Toxicology Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Genetic Toxicology Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Genetic Toxicology Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application

10. Middle East and Africa Genetic Toxicology Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Genetic Toxicology Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Genetic Toxicology Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Genetic Toxicology Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
  • 10.3.4. Egypt Genetic Toxicology Testing Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Component
      • 10.3.4.2.2. By Type
      • 10.3.4.2.3. By Application
  • 10.3.5. Turkey Genetic Toxicology Testing Market Outlook
    • 10.3.5.1. Market Size & Forecast
      • 10.3.5.1.1. By Value
    • 10.3.5.2. Market Share & Forecast
      • 10.3.5.2.1. By Component
      • 10.3.5.2.2. By Type
      • 10.3.5.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Product Offerings
• 13.3. Recent Developments
• 13.4. Financials (As Reported)
• 13.5. Key Personnel
• 13.6. SWOT Analysis
  • 13.6.1. Thermo Fisher Scientific, Inc.
  • 13.6.2. Eurofins Scientific SE
  • 13.6.3. Jubilant Life Sciences Limited
  • 13.6.4. Syngene International Limited
  • 13.6.5. Gentronix Ltd.
  • 13.6.6. Inotiv Inc.
  • 13.6.7. Charles River Laboratories International, Inc.
  • 13.6.8. Merck KGaA
  • 13.6.9. Toxikon Corporation
  • 13.6.10. Gentronix Limited

14. Strategic Recommendations